Adia Nutrition (ADIA) Capital Leases (2024 - 2026)
Adia Nutrition's (ADIA) quarterly Capital Leases came in at $55586.0 in Q1 2026, down 9.45% quarter-over-quarter from $61387.0 in Q4 2025.
Analysis
Adia Nutrition (ADIA) Capital Leases (2024 - 2026) Analysis & Trends
Adia Nutrition (ADIA) has reported Capital Leases for 3 consecutive years, with $55586.0 the latest figure, recorded in Q1 2026.
- On a quarterly basis, Capital Leases changed N/A year-over-year to $55586.0 in Q1 2026; TTM through Mar 2026 was $55586.0, a N/A change from a year earlier, with the FY2025 full-year figure at $61387.0, down 30.27% from the prior year.
- Capital Leases was $55586.0 for Q1 2026 at Adia Nutrition, down from $61387.0 in the prior quarter.
- Over five years, Capital Leases peaked at $88030.0 in Q4 2024 and troughed at $55586.0 in Q1 2026.
- A 3-year average of $68334.3 and a median of $61387.0 in 2025 frame the typical range for Capital Leases.
- The widest YoY moves for Capital Leases: up 30.27% in 2025, down 30.27% in 2025.
- Over 3 years, Capital Leases stood at $88030.0 in 2024, then slumped by 30.27% to $61387.0 in 2025, then declined by 9.45% to $55586.0 in 2026.
- The last three Capital Leases figures came in at $55586.0 (Q1 2026), $61387.0 (Q4 2025), and $88030.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 9.96 Bn | 9.12 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.47 Bn | 5.47 Bn | - |
| 3 | Iovance Biotherapeutics | 4.64 Bn | 4.35 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.25 Bn | 2.28 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Precigen | 2.79 Bn | 2.79 Bn | 52.17 Mn |
| 7 | Beam Therapeutics | 2.58 Bn | 2.58 Bn | - |
| 8 | Sarepta Therapeutics | 2.12 Bn | 1.33 Bn | 251.87 Mn |
| 9 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn |
| 10 | Adia Nutrition | 11.33 Mn | 11.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 55,586.00 |
| Dec 31, 2025 | 61,387.00 |
| Dec 31, 2024 | 88,030.00 |